Trends in malaria chemoprophylaxis prescription in South Africa 1994 to 2000

Journal of Travel Medicine

Volumn 9, Issue 6, 2002, Pages 318-321

  Leggat, Peter A ^a,b   Dürrheim, David N ^a   Blumberg, Lucille ^c  

^a JAMES COOK UNIVERSITY   (Australia)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ATOVAQUONE PLUS PROGUANIL; CHLOROQUINE; DOXYCYCLINE; FANSIDAR; FOLIC ACID ANTAGONIST; MALOPRIM; MEFLOQUINE; PROGUANIL;

AGRANULOCYTOSIS; ARTICLE; BLOOD TOXICITY; CHEMOPROPHYLAXIS; DRUG EFFECT; DRUG USE; HUMAN; MALARIA FALCIPARUM; PRACTICE GUIDELINE; PRESCRIPTION; SOUTH AFRICA; DRUG COMBINATION; DRUG COST; ECONOMICS; MALARIA; STATISTICS;

ANTIMALARIALS; CHLOROGUANIDE; CHLOROQUINE; DRUG COMBINATIONS; DRUG COSTS; DRUG UTILIZATION REVIEW; HUMANS; MALARIA; MEFLOQUINE; PRESCRIPTIONS, DRUG; SOUTH AFRICA;

EID: 1842863884     PISSN: 11951982     EISSN: None     Source Type: Journal    
DOI: 10.2310/7060.2002.30173     Document Type: Article

References (20)

1. World Health Organization. Information Sheet 1, Malaria. Available at http://www.int/health-tropicalmalaria.htm (accessed September 26, 2002).
2. Dürrheim DN, Ogunbanjo GA, Blumberg L. Managing reemergent malaria in South Africa. S A Fam Pract 1999; 21:19-24.
3. Nchinda TC. Malaria: A reemerging disease in Africa. Emerg Infect Dis 1998; 4:398-403.
4. Lobel HO, Campbell CC, Roberts JM. Fatal malaria in US citizens. Lancet 1985; 1:873.
5. Lewis SJ, Davidson RN, Ross EJ, Hall AP. Severity of imported malaria: Effect of taking antimalarial prophylaxis. BMJ 1992; 305:741-743.
6. Behrens RH. Protecting the health of the international traveller. Trans R Soc Trop Med Hyg 1990; 84:611-612, 629.
7. Dürrheim DN, Leggat PA. Prophylaxis against malaria. Preventing mosquito bites is also effective. BMJ 1999; 318:1139.
8. Schapira A. Chloroquine resistant malaria in Africa: The challenge to the health services. Health Policy and Planning 1989; 4:17-28.
9. Freese JA, Sharp BL, Ngxongo SM, Markus MB. In vitro confirmation of chloroquine-resistant Plasmodium falciparum malaria in KwaZulu. S Afr Med J 1988; 74:576-578.
10. Kruger P, Dürrheim DN, Hansford CF. Increasing chloroquine resistance - The Mpumalanga Lowveld story, 1990-1995. S Afr Med J 1996; 86:280-281.
11. Department of Health. Guidelines for the Prophylaxis of Malaria. Pretoria: South African National Department of Health, 1996.
12. Dürrheim DN, Gammon S, Waner S, Braack LE. Antimalarial prophylaxis: Use and adverse events in visitors to the Kruger National Park. S Afr Med J 1999; 89:170-175.
13. Waner S, Dürrheim DN, Braack LE, Gammon S. Malaria protection measures used by in-flight travelers to South African game parks. J Travel Med 1999; 6:254-257.
14. Govere JM, la Grange JJ, Dürrheim DN, et al. Sulfadoxinepyrimethamine effectiveness against Plasmodium falciparum malaria in Mpumalanga Province, South Africa. Trans R Soc Trop Med Hyg 1999; 93:644.
15. Anonymous. Malaria deaths following inappropriate malaria chemoprophylaxis: United States, 2001. MMWR 2001; 50:597-599.
16. Shanks GD. Drugs for the prophylaxis and treatment of malaria. J Travel Med 1994; 1:40-47.
17. Phillips-Howard PA, West LJ. Severe adverse reactions to pyrimethamine-sulphadoxine, pyrimethamine-dapsone and amodiaquine in Britain. J R Soc Med 1990; 83:82-85.
18. Bradley DJ, Warhurst DC. Malaria prophylaxis: Guidelines for travel from Britain. BMJ 1995; 310:709-714.
19. Leggat PA, Heydon JL, Menon A. Malaria prophylaxis prescribed for travellers from New Zealand. N Z Med J 1997; 110:319-321.
20. Coole L, Wiselka MJ, Nicholson KG. Malaria prophylaxis in travellers from Britain. J Infect 1989; 18:209-212.